{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:19:09Z","timestamp":1784067549396,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.jaut.2005.11.001","type":"journal-article","created":{"date-parts":[[2005,12,28]],"date-time":"2005-12-28T10:00:24Z","timestamp":1135764024000},"page":"82-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Type 2 autoimmune hepatitis murine model: The influence of genetic background in disease development"],"prefix":"10.1016","volume":"26","author":[{"given":"Pascal","family":"Lapierre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathie","family":"B\u00e9land","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idriss","family":"Djilali-Saiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2005.11.001_bib1","series-title":"Liver disease in childhood","article-title":"Autoimmune hepatitis","author":"Alvarez","year":"2001"},{"key":"10.1016\/j.jaut.2005.11.001_bib2","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jaut.2005.11.001_bib3","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199604043341406","article-title":"Autoimmune hepatitis","volume":"334","author":"Krawitt","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaut.2005.11.001_bib4","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.1840080632","article-title":"Antibody to liver cytosol (anti-LCI) in patients with autoimmune chronic active hepatitis type 2","volume":"8","author":"Martini","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2005.11.001_bib5","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.1840070626","article-title":"Chronic active hepatitis associated with antiliver\/kidney microsome antibody type 1: a second type of \u201cautoimmune\u201d hepatitis","volume":"7","author":"Homberg","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2005.11.001_bib6","first-page":"376","article-title":"Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents","volume":"17","author":"Maggiore","year":"1993","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaut.2005.11.001_bib7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1084\/jem.168.2.801","article-title":"Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily","volume":"168","author":"Gueguen","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaut.2005.11.001_bib8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0016-5085(99)70186-1","article-title":"Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis","volume":"116","author":"Lapierre","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2005.11.001_bib9","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0021-9258(18)69935-1","article-title":"The enzymatic formation of formiminotetrahydrofolic acid, 5,10-methenyltetrahydrofolic acid, and 10-formyltetrahydrofolic acid in the metabolism of formiminoglutamic acid","volume":"234","author":"Tabor","year":"1959","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaut.2005.11.001_bib10","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/331442a0","article-title":"Characterization of the common genetic defect in humans deficient in debrisoquine metabolism","volume":"331","author":"Gonzalez","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2005.11.001_bib11","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.20109","article-title":"A murine model of type 2 autoimmune hepatitis: xenoimmunization with human antigens","volume":"39","author":"Lapierre","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2005.11.001_bib12","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1172\/JCI108121","article-title":"Genetic analysis of patients with chronic active hepatitis","volume":"56","author":"Page","year":"1975","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaut.2005.11.001_bib13","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(72)92149-6","article-title":"Association of autoimmune active chronic hepatitis with HL-A1, 8","volume":"2","author":"Mackay","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2005.11.001_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(77)91080-7","article-title":"Genetic factors in the development of chronic active hepatitis","volume":"1","author":"Lindberg","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2005.11.001_bib15","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0198-8859(01)00344-5","article-title":"CTLA-4\/CD 28 region polymorphisms in children from families with autoimmune hepatitis","volume":"62","author":"Djilali-Saiah","year":"2001","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaut.2005.11.001_bib16","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.510300412","article-title":"Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis","volume":"30","author":"Cookson","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2005.11.001_bib17","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jhep.2004.02.023","article-title":"Linkage disequilibrium between HLA class II region and autoimmune hepatitis in pediatric patients","volume":"40","author":"Djilali-Saiah","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jaut.2005.11.001_bib18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/hep.1840130415","article-title":"Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors","volume":"13","author":"Donaldson","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2005.11.001_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0016-5085(80)90080-3","article-title":"HLA associations with autoimmune-type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies","volume":"79","author":"Mackay","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2005.11.001_bib20","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0016-5085(92)90041-V","article-title":"HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients","volume":"103","author":"Seki","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2005.11.001_bib21","article-title":"Current protocols in immunology","year":"2000"},{"key":"10.1016\/j.jaut.2005.11.001_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0022-1759(02)00016-9","article-title":"Autoantibody detection in type 2 autoimmune hepatitis using a chimera recombinant protein","volume":"262","author":"Vitozzi","year":"2002","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jaut.2005.11.001_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/hep.1840110106","article-title":"Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity","volume":"11","author":"Lohse","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2005.11.001_bib24","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.4049\/jimmunol.166.10.6413","article-title":"Genetic regulation of autoimmune disease: BALB\/c background TGF-beta 1-deficient mice develop necroinflammatory IFN-gamma-dependent hepatitis","volume":"166","author":"Gorham","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2005.11.001_bib25","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/0891693021000056721","article-title":"Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease","volume":"35","author":"Gregorio","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2005.11.001_bib26","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.humimm.2004.03.004","article-title":"Simultaneous expression of Th1 cytokines and IL-4 confers severe characteristics to type I autoimmune hepatitis in children","volume":"65","author":"Chernavsky","year":"2004","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaut.2005.11.001_bib27","doi-asserted-by":"crossref","first-page":"916","DOI":"10.4049\/jimmunol.137.3.916","article-title":"Slower processing, weaker beta 2-M association, and lower surface expression of H-2Ld are influenced by its amino terminus","volume":"137","author":"Beck","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2005.11.001_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","article-title":"Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease","volume":"41","author":"Longhi","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jaut.2005.11.001_bib29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nri821","article-title":"CD4+CD25+ suppressor T cells: more questions than answers","volume":"2","author":"Shevach","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaut.2005.11.001_bib30","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1128\/IAI.70.9.4833-4840.2002","article-title":"Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy","volume":"70","author":"Katae","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.jaut.2005.11.001_bib31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vetimm.2004.12.006","article-title":"Assessment in mice of vapA-DNA vaccination against Rhodococcus equi infection","volume":"104","author":"Haghighi","year":"2005","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.jaut.2005.11.001_bib32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1046\/j.1365-2567.1999.00668.x","article-title":"Prognostic importance of antigen-presenting dendritic cells during vaccine therapy in a murine hepatitis B virus carrier","volume":"96","author":"Akbar","year":"1999","journal-title":"Immunology"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841105001745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841105001745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T07:57:22Z","timestamp":1760255842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841105001745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0896841105001745"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2005.11.001","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 2 autoimmune hepatitis murine model: The influence of genetic background in disease development","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2005.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}